Cargando…

Histone deacetylase inhibitors potentiate photodynamic therapy in colon cancer cells marked by chromatin-mediated epigenetic regulation of CDKN1A

BACKGROUND: Hypericin-mediated photodynamic therapy (HY-PDT) has recently captured increased attention as an alternative minimally invasive anticancer treatment, although cancer cells may acquire resistance. Therefore, combination treatments may be necessary to enhance HY-PDT efficacy. Histone deace...

Descripción completa

Detalles Bibliográficos
Autores principales:	Halaburková, Andrea, Jendželovský, Rastislav, Kovaľ, Ján, Herceg, Zdenko, Fedoročko, Peter, Ghantous, Akram
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5465463/ https://www.ncbi.nlm.nih.gov/pubmed/28603560 http://dx.doi.org/10.1186/s13148-017-0359-x

Ejemplares similares

Potentiality, Limitations, and Consequences of Different Experimental Models to Improve Photodynamic Therapy for Cancer Treatment in Relation to Antiangiogenic Mechanism
por: Majerník, Martin, et al.
Publicado: (2020)

Pan-cancer multi-omics analysis and orthogonal experimental assessment of epigenetic driver genes
por: Halaburkova, Andrea, et al.
Publicado: (2020)

Multifunctional Nanoplatforms as a Novel Effective Approach in Photodynamic Therapy and Chemotherapy, to Overcome Multidrug Resistance in Cancer
por: Majerník, Martin, et al.
Publicado: (2022)

Hypericin in the Light and in the Dark: Two Sides of the Same Coin
por: Jendželovská, Zuzana, et al.
Publicado: (2016)

Novel Insights into the Effect of Hyperforin and Photodynamic Therapy with Hypericin on Chosen Angiogenic Factors in Colorectal Micro-Tumors Created on Chorioallantoic Membrane
por: Majerník, Martin, et al.
Publicado: (2019)

Histone deacetylases in RA: epigenetics and epiphenomena
por: Grabiec, Aleksander M, et al.
Publicado: (2010)

Histone Deacetylases and Their Inhibitors in Cancer Epigenetics
por: Hassell, Kelly N.
Publicado: (2019)

Death Receptor 5 (TNFRSF10B) Is Upregulated and TRAIL Resistance Is Reversed in Hypoxia and Normoxia in Colorectal Cancer Cell Lines after Treatment with Skyrin, the Active Metabolite of Hypericum spp.
por: Babinčák, Marián, et al.
Publicado: (2021)

Tacrine-Coumarin Derivatives as Topoisomerase Inhibitors with Antitumor Effects on A549 Human Lung Carcinoma Cancer Cell Lines
por: Konkoľová, Eva, et al.
Publicado: (2021)

Acridine Based N-Acylhydrazone Derivatives as Potential Anticancer Agents: Synthesis, Characterization and ctDNA/HSA Spectroscopic Binding Properties
por: Vilková, Mária, et al.
Publicado: (2022)

New findings on the action of hypericin in hypoxic cancer cells with a focus on the modulation of side population cells
por: Buľková, Viktória, et al.
Publicado: (2023)

Predicting chromatin organization using histone marks
por: Huang, Jialiang, et al.
Publicado: (2015)

Histone deacetylase inhibition leads to regulatory histone mark alterations and impairs meiosis in oocytes
por: Legoff, Louis, et al.
Publicado: (2021)

Histone Deacetylase Inhibitors, Intrinsic and Extrinsic Apoptotic Pathways, and Epigenetic Alterations of Histone Deacetylases (HDACs) in Hepatocellular Carcinoma
por: Sanaei, Masumeh, et al.
Publicado: (2021)

Epigenetic Targeting of Histone Deacetylases in Diagnostics and Treatment of Depression
por: Park, Hyun-Sun, et al.
Publicado: (2021)

Histone Deacetylases as Epigenetic Targets for Treating Parkinson’s Disease
por: Li, Yan, et al.
Publicado: (2022)

Patho-epigenetics: histone deacetylases as targets of pathogens and therapeutics
por: Schator, Daniel, et al.
Publicado: (2021)

Lysine-14 acetylation of histone H3 in chromatin confers resistance to the deacetylase and demethylase activities of an epigenetic silencing complex
por: Wu, Mingxuan, et al.
Publicado: (2018)

Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma
por: Phimmachanh, Monica, et al.
Publicado: (2020)

DNA methylation of insulin-like growth factor 2 and H19 cluster in cord blood and prenatal air pollution exposure to fine particulate matter
por: Wang, Congrong, et al.
Publicado: (2020)

Interrelationships and determinants of aging biomarkers in cord blood
por: Reimann, Brigitte, et al.
Publicado: (2022)

MAPK-triggered chromatin reprogramming by histone deacetylase in plant innate immunity
por: Latrasse, David, et al.
Publicado: (2017)

Epigenetic Modifiers in Myeloid Malignancies: The Role of Histone Deacetylase Inhibitors
por: Ungerstedt, Johanna S.
Publicado: (2018)

Unraveling the Epigenetic Role and Clinical Impact of Histone Deacetylases in Neoplasia
por: Goutas, Dimitrios, et al.
Publicado: (2021)

Histone deacetylase 10, a potential epigenetic target for therapy
por: Cheng, Fajuan, et al.
Publicado: (2021)

Psychostimulants and opioids differentially influence the epigenetic modification of histone acetyltransferase and histone deacetylase in astrocytes
por: Doke, Mayur, et al.
Publicado: (2021)

Epigenetic remodelling of enhancers in response to estrogen deprivation and re-stimulation
por: Sklias, Athena, et al.
Publicado: (2021)

Evaluation of histone deacetylase inhibitor substituted zinc and indium phthalocyanines for chemo- and photodynamic therapy
por: Aru, Başak, et al.
Publicado: (2021)

Antagonistic and synergistic epigenetic modulation using orthologous CRISPR/dCas9-based modular system
por: Josipović, Goran, et al.
Publicado: (2019)

Epigenetic therapies in acute myeloid leukemia: the role of hypomethylating agents, histone deacetylase inhibitors and the combination of hypomethylating agents with histone deacetylase inhibitors
por: Xu, Qing-Yu, et al.
Publicado: (2020)

From hepatitis to hepatocellular carcinoma: a proposed model for cross-talk between inflammation and epigenetic mechanisms
por: Martin, Marion, et al.
Publicado: (2012)

Histone deacetylase inhibitor-based chromatin precipitation for identification of targeted genomic loci
por: Hanigan, Thomas W., et al.
Publicado: (2018)

New clinical developments in histone deacetylase inhibitors for epigenetic therapy of cancer
por: Cang, Shundong, et al.
Publicado: (2009)

Histone Deacetylase Inhibitors: The Epigenetic Therapeutics That Repress Hypoxia-Inducible Factors
por: Chen, Shuyang, et al.
Publicado: (2011)

Editorial: Epigenetic Therapy With Histone Deacetylase Inhibitors: Implications for Cancer Treatment
por: Sousa, Angela, et al.
Publicado: (2021)

Epigenetic marking of sperm by post-translational modification of histones and protamines
por: Brunner, Andrea M, et al.
Publicado: (2014)

Imprinted CDKN1C Is a Tumor Suppressor in Rhabdoid Tumor and Activated by Restoration of SMARCB1 and Histone Deacetylase Inhibitors
por: Algar, Elizabeth M., et al.
Publicado: (2009)

In vitro investigating of anticancer activity of new 7-MEOTA-tacrine heterodimers
por: Janockova, Jana, et al.
Publicado: (2019)

Enrichment of rare alleles within epigenetic chromatin marks in the first intron
por: Jo, Shin-Sang, et al.
Publicado: (2019)

The epigenetic players and the chromatin marks involved in the articular cartilage during osteoarthritis
por: Lafont, Jérôme E., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_o1s47clb2garro8sa8qmkhc5bv